Skip to main content

Table 2 The characteristics of 538 CRC patients from TCGA

From: Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients

 

Type

Patients

Fustat

Alive

431 (80.1%)

Dead

107 (19.9%)

Age

≤ 65

232 (43.1%)

> 65

306 (56.9%)

Type

Adenocarcinoma

538 (98.5%)

Not clear

8 (1.5%)

Sex

Male

254 (47.2%)

Female

284 (52.8%)

Stage

I

95 (17.7%)

II

208 (38.7%)

III

149 (27.6%)

IV

86 (16.0%)

T-stage

T1

17 (3.2%)

T2

92 (17.1%)

T3

372 (69.1%)

T4

57 (10.6%)

M-stage

M0

452 (84.0%)

M1

86 (16.0%)

N-stage

N0

313 (58.2%)

N1

128 (23.8%)

N2

97 (18.0%)

Location

Colon

389 (72.3%)

Rectum

141 (26.2%)

Not clear

8 (1.5%)